Favipiravir: An Effective Rna Polymerase Modulating Anti-Influenza Drug-Reference-Cited by-同舟云学术

Favipiravir: An Effective Rna Polymerase Modulating Anti-Influenza Drug

Published:2023-06-30 Issue:2 Volume:20 Page:465-475
ISSN:2456-2602
Container-title:Biosciences Biotechnology Research Asia
language:en
Short-container-title:Biosci., Biotech. Res. Asia

Author:

Yash Shertate¹^ORCID,Sarika Kamble¹^ORCID,Laxmikant Borse²^ORCID

Affiliation:

1. 1Department of Quality Assurance, Sandip Foundation’s Sandip Institute of Pharmaceutical Science,Affiliated to Savitribai Phule Pune University, Mahiravani, Nashik, Maharashtra 422213, India

2. 2Department of Pharmacology, Sandip Foundation’s Sandip Institute of Pharmaceutical Science, Affiliated to Savitribai Phule Pune University, Mahiravani, Nashik, Maharashtra 422213, India

Abstract

ABSTRACT: Combination of all the aspects are covered in this review from anti-influenza drug.Several articles neglected to include a point of view. The majority of review papers emphasiseon epidemiology. In order to lessen the financial burden of disease and its negative effects, it is important to raise awareness about disease and how to manage it.The medicine favipiravir,additionally called T-705 (5-fluro-2-oxo-1H-pyrazine-3-carboxamide), by selection and powerfully inhibits the polymer-dependent polymer accelerator (RdRp) of polymer viruses. Favipiravir was discovred by the company Toyama Chemical Co., Ltd.By searching a chemical library for the respiratory illness virus's antiviral properties. Favipiravir-RTP (favipiravir ribofuranosyl-5′-triphosphate), the active version of the drug, is recognised by RdRpas a substrate and restrains the polymer accelerator's activityFavipiravir is efficient against a broad kind of subtypes and variations of respiratory disorder viruses.

Publisher

Oriental Scientific Publishing Company

Subject

Drug Discovery,Agronomy and Crop Science,Biotechnology

Reference70 articles.

1. Wille, Michelle, and Ian G. Barr. “Resurgence of avian influenza virus.” Science6592 (2022): 459-460.

2. Sun, Yanxia, et al. “High activity levels of avian influenza upwards 2018–2022: A global epidemiological overview of fowl and human infections.” One Health(2023): 100511.

3. Peersen, Olve B. “A comprehensive superposition of viral polymerase structures.” Viruses8 (2019): 745.

4. Muratov, Eugene. “Praemonituspraemunitus: can we forecast and prepare for future viral disease outbreaks?.” Authorea Preprints(2022).

5. Arruda, Liã Bárbara, et al. “The niche of One Health approaches in Lassa fever surveillance and control.” Annals of clinical microbiology and antimicrobials1 (2021): 29.